Armata Pharmaceuticals, Inc. Common Stock (ARMP)

Let's have a look at the stocks with an unusual volume in today's session.

Discover the top movers in Thursday's pre-market session and stay informed about market dynamics.

H.C. Wainwright reiterated a ‘Buy’ rating and $9 target, saying the results support advancing AP-SA02 into Phase 3 next year.

Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics.

Which stocks have an unusual volume on Tuesday?

Let's have a look at what is happening on the US markets after the closing bell on Monday. Below you can find the top gainers and losers in today's after hours session.

ARMP stock results show that Armata Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2024.

Discover three high-growth stock picks set for unprecedented surges in the metals, marine transportation, and pharmaceutical industries.

ARMP stock results show that Armata Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

ARMP stock results show that Armata Pharmaceuticals missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.

Gainers Silicon Motion Technology Corporation (NASDAQ: SIMO) shares climbed 78.9% to $93.40 following a report suggesting China approval of the company's Maxlinear merger.